Based on recently published immunological data, COVID-19 patients have a dysregulated immune response, characterized by the release of multiple inflammatory cytokines, such as tumor necrosis factor (TNF), interleukins, as well as a decreased number of T cells, B cells, and natural killer (NK) cells [8]. Here, TNF is linked to COVID-19.